GSK Consumer Tries On Wearable Pain Relief With NeuroMetrix Deal
This article was originally published in The Pink Sheet & The Rose Sheet
Executive Summary
GSK Consumer purchases ex-US rights to pain relief device Quell from NeuroMetrix in a deal that includes co-development of transcutaneous electrical nerve stimulation products.